Telephone
61.2.9855.5444
Address
Level 22 225 George Street Grosvenor Place Sydney, New South Wales (NSW) 2000
Description
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. It operates through the following segments: Laboratory, Radiology, and Other. The Laboratory segment offers pathology and clinical services. The Radiology segment is involved in diagnostic imaging services in Australia. The Other segment refers to the corporate office function, medical center operations and occupation health services, and other minor operations. The company was founded on September 25, 1934, and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 23.58 - 32.57
Trade Value (12mth)
AU$9,321,423.00
1 week
-1.95%
1 month
0.82%
YTD
-15.74%
1 year
-13.4%
All time high
46.95
EPS 3 yr Growth
-61.00%
EBITDA Margin
15.60%
Operating Cashflow
$1,072m
Free Cash Flow Return
9.60%
ROIC
4.60%
Interest Coverage
8.90
Quick Ratio
0.90
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
20-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
1.24
Date | Announcements |
---|---|
04 September 24 |
Notification regarding unquoted securities - SHL
×
Notification regarding unquoted securities - SHL |
02 September 24 |
Notification regarding unquoted securities - SHL
×
Notification regarding unquoted securities - SHL |
27 August 24 |
Notification of cessation of securities - SHL
×
Notification of cessation of securities - SHL |
22 August 24 |
Preliminary Final Report
×
Preliminary Final Report |
22 August 24 |
Dividend/Distribution - SHL
×
Dividend/Distribution - SHL |
22 August 24 |
Media Release - Full Year Results to 30 June 2024
×
Media Release - Full Year Results to 30 June 2024 |
22 August 24 |
CEO Presentation - Full Year Results to 30 June 2024
×
CEO Presentation - Full Year Results to 30 June 2024 |
01 August 24 |
Sonic Healthcare to raise EUR400M of long term debt funding
×
Sonic Healthcare to raise EUR400M of long term debt funding |
31 May 24 |
Notification regarding unquoted securities - SHL
×
Notification regarding unquoted securities - SHL |
30 May 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 May 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 May 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
27 May 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
23 May 24 |
Notification of cessation of securities - SHL
×
Notification of cessation of securities - SHL |
21 May 24 |
Sonic Healthcare Earnings Update
×
Sonic Healthcare Earnings Update |
24 April 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
24 April 24 |
Change in substantial holding
×
Change in substantial holding |
09 April 24 |
Application for quotation of securities - SHL
×
Application for quotation of securities - SHL |
04 April 24 |
Application for quotation of securities - SHL
×
Application for quotation of securities - SHL |
25 March 24 |
Application for quotation of securities - SHL
×
Application for quotation of securities - SHL |
20 March 24 |
Acquisition of Dr Risch Group, Switzerland
×
Acquisition of Dr Risch Group, Switzerland |
20 March 24 |
Proposed issue of securities - SHL
×
Proposed issue of securities - SHL |
14 March 24 |
Hertfordshire and West Essex NHS Contract in UK
×
Hertfordshire and West Essex NHS Contract in UK |
14 March 24 |
Application for quotation of securities - SHL
×
Application for quotation of securities - SHL |
08 March 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.